Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 493

1.

Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida.

Shaw GM, Rozen R, Finnell RH, Wasserman CR, Lammer EJ.

Am J Epidemiol. 1998 Jul 1;148(1):30-7.

PMID:
9663401
[PubMed - indexed for MEDLINE]
Free Article
2.

Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects.

Volcik KA, Shaw GM, Lammer EJ, Zhu H, Finnell RH.

Birth Defects Res A Clin Mol Teratol. 2003 Mar;67(3):154-7.

PMID:
12797455
[PubMed - indexed for MEDLINE]
3.

Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida.

Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH.

Am J Med Genet. 2002 Feb 15;108(1):1-6. Erratum in: Am J Med Genet 2002 Dec 15;113(4):392.

PMID:
11857541
[PubMed - indexed for MEDLINE]
4.

Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip.

Shaw GM, Rozen R, Finnell RH, Todoroff K, Lammer EJ.

Am J Med Genet. 1998 Nov 16;80(3):196-8.

PMID:
9843036
[PubMed - indexed for MEDLINE]
5.

The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy.

de Franchis R, Buoninconti A, Mandato C, Pepe A, Sperandeo MP, Del Gado R, Capra V, Salvaggio E, Andria G, Mastroiacovo P.

J Med Genet. 1998 Dec;35(12):1009-13.

PMID:
9863598
[PubMed - indexed for MEDLINE]
Free PMC Article
6.
7.

Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate?

van Rooij IA, Vermeij-Keers C, Kluijtmans LA, Ocké MC, Zielhuis GA, Goorhuis-Brouwer SM, van der Biezen JJ, Kuijpers-Jagtman AM, Steegers-Theunissen RP.

Am J Epidemiol. 2003 Apr 1;157(7):583-91.

PMID:
12672677
[PubMed - indexed for MEDLINE]
Free Article
8.

Interaction between maternal periconceptional supplementation of folic acid and reduced folate carrier gene polymorphism of neural tube defects.

Pei LJ, Zhu HP, Li ZW, Zhang W, Ren AG, Zhu JH, Li Z.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Jun;22(3):284-7.

PMID:
15952116
[PubMed - indexed for MEDLINE]
9.

Methylenetetrahydrofolate reductase and spina bifida: evaluation of level of defect and maternal genotypic risk in Hispanics.

Volcik KA, Blanton SH, Tyerman GH, Jong ST, Rott EJ, Page TZ, Romaine NK, Northrup H.

Am J Med Genet. 2000 Nov 6;95(1):21-7.

PMID:
11074490
[PubMed - indexed for MEDLINE]
10.

Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes.

Shaw GM, Iovannisci DM, Yang W, Finnell RH, Carmichael SL, Cheng S, Lammer EJ.

Am J Med Genet A. 2005 Sep 15;138(1):21-6.

PMID:
16100725
[PubMed - indexed for MEDLINE]
11.

[Frequency of C677T polymorphism of 5, 10-methylenetetrahydrofolate reductase (MTHFR) in Chilean mothers of spina bifida cases and controls ].

Nitsche F, Alliende MA, Santos JL, Pérez F, Santa María L, Hertrampf E, Cortés F.

Rev Med Chil. 2003 Dec;131(12):1399-404. Spanish.

PMID:
15022402
[PubMed - indexed for MEDLINE]
12.

Association of reduced folate carrier gene polymorphism and maternal folic acid use with neural tube defects.

Pei L, Liu J, Zhang Y, Zhu H, Ren A.

Am J Med Genet B Neuropsychiatr Genet. 2009 Sep 5;150B(6):874-8. doi: 10.1002/ajmg.b.30911.

PMID:
19105199
[PubMed - indexed for MEDLINE]
13.

Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects.

Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R, Gilfix BM, Rosenblatt DS, Gravel RA, Forbes P, Rozen R.

Am J Med Genet. 1999 May 21;84(2):151-7.

PMID:
10323741
[PubMed - indexed for MEDLINE]
14.

Survival of infants with neural tube defects in the presence of folic acid fortification.

Bol KA, Collins JS, Kirby RS; National Birth Defects Prevention Network.

Pediatrics. 2006 Mar;117(3):803-13.

PMID:
16510661
[PubMed - indexed for MEDLINE]
Free Article
15.

Folate status and neural tube defects.

Molloy AM, Mills JL, Kirke PN, Weir DG, Scott JM.

Biofactors. 1999;10(2-3):291-4.

PMID:
10609896
[PubMed - indexed for MEDLINE]
16.

Spina bifida and other neural tube defects.

Northrup H, Volcik KA.

Curr Probl Pediatr. 2000 Nov-Dec;30(10):313-32. Review.

PMID:
11147289
[PubMed - indexed for MEDLINE]
17.

Methylenetetrahydrofolate reductase, diet, and risk of colon cancer.

Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M.

Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):513-8.

PMID:
10385141
[PubMed - indexed for MEDLINE]
Free Article
18.

The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifida.

van der Linden IJ, den Heijer M, Afman LA, Gellekink H, Vermeulen SH, Kluijtmans LA, Blom HJ.

J Mol Med (Berl). 2006 Dec;84(12):1047-54. Epub 2006 Oct 6.

PMID:
17024475
[PubMed - indexed for MEDLINE]
19.

Microsatellites proximal to leptin and leptin receptor as risk factors for spina bifida.

Shaw GM, Barber R, Todoroff K, Lammer EJ, Finnell RH.

Teratology. 2000 Mar;61(3):231-5.

PMID:
10661913
[PubMed - indexed for MEDLINE]
20.

Polymorphisms of 5,10-methylenetetrahydrofolate reductase and cystathionine beta-synthase genes as a risk factor for neural tube defects in Sétif, Algeria.

Houcher B, Bourouba R, Djabi F, Yilmaz E, Eğin Y, Akar N.

Pediatr Neurosurg. 2009;45(6):472-7. doi: 10.1159/000283086. Epub 2010 Feb 16.

PMID:
20160465
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk